Category: Vaccines
North America Vaccines
-
2024 United States Pediatric Vaccines Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2033
... in the United States has experienced significant growth in recent years, driven by various factors including heightened public awareness of infectious diseases and the ongoing innovations in vaccine technology. As of 2024, the market is ... Read More
-
North America Pharmacokinetics Services Market Forecast to 2031 - Regional Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)
... Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others) The North America ... Read More
-
North America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
... Disease (Avian Influenza, Salmonellosis, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary ... Read More
-
North America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The North America bioprocessing market was valued at US$ 12,440.60 million in 2023 and is expected ... Read More
-
Biological Product (except Diagnostic) Manufacturing - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... of the industry in the United States with over 100 data sets covering 2015-2028. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the ... Read More
-
Temperature-controlled Packaging for Pharmaceutical Market Research Report Information by Product (Shippers and Containers), by Type (Active System and Passive System), by Temperature Range (-20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), Medicine Type (Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine), by End-use Industry (Pharmaceuticals and Clinical Trails), and by Region (North America, Europe, Asia Pacific, and Rest of the World) – Industry Forecast Till 2030
... and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), ... Read More
-
Vaccines Market, By Type (Monovalent Vaccines , Multitvalent Vaccines), By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Other Vaccine Technologies), By Disease Indication (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Artificial Retina Implant Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
... User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032 In 2025, the Artificial Retina Implant Market was estimated to ... Read More
-
Biodefense Market Research Report Information by Disease Type (Anthrax, Smallpox, Botulism, Influenza, Radiation/Nuclear, And Others) by Treatment (Vaccination, And Medication), by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2030
... 2030 Over the course of the forecast period, the Biodefense Market is expected to grow at a compound annual growth rate (CAGR) of 7.01%. To be prepared for any bioterrorism strikes, governments are investing a ... Read More
-
Blue Biotechnology Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
... (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032 The Blue Biotechnology Market is expected to increase at a compound ... Read More
-
US Vaccine Logistics Market Size study, by Service (Transportation, Warehousing, Value-added Services) by End User (Hospitals, Drug Manufacturers and Distributors, Other End Users) Forecasts 2022-2032
... in 2023 and is anticipated to grow with a healthy growth rate of more than 5.18% over the forecast period 2024-2032. Vaccine logistics includes organizing and carrying out tasks associated with the distribution, delivery, storage, ... Read More
-
US Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) Forecasts 2022-2032
... Pneumococcal Vaccine Market is valued approximately USD 3.67 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.90% over the forecast period 2024-2032. The Pneumococcal Vaccine is a ... Read More
-
North America Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Country 2024-2032
... North America travel vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. ... Read More
-
North America Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-Sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Country 2024-2032
... The North America pharmaceutical contract packaging market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% ... Read More
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Downstream processing refers to the purification and recovery steps in bioprocessing undertaken ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The single-use ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
US AAV Contract Development and Manufacturing Organizations Market Size study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User Forecasts 2022-2032
... End-User Forecasts 2022-2032 US AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 201.14 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.85% over ... Read More
-
US Medical Drone Market Size study, by Drone Type (Rotor Drones, Fixed Wing Drones, Hybrid Drones) By Application (Blood Bank Transportation, Vaccines Transportation, Organs Transportation, Others) By End User (Hospitals, Blood Banks, Government Institutions, Others) Forecasts 2022-2032
... Forecasts 2022-2032 US Medical Drone Market is valued approximately USD xx million in 2023 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2024-2032. A medical ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414
... Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: ... Read More
-
Bioprocessing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
... (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & ... Read More
-
North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031
... 2031 The North America Ruminant Vaccines Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031). The US market dominated the North America Ruminant Vaccines Market by Country in 2023, and would ... Read More
-
North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2024-2032
... 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing cellular therapies and biomarker testing, escalating need to reduce ... Read More
Research Assistance
